跳至主要内容
临床试验/DRKS00022509
DRKS00022509招募中不适用

Prospective pilotstudy for the development and evaluation of softwaretools for non-invasive assessment of fibrosis and steatosis of the liver with machine learning methods

Goethe-Universität Frankfurt am Main0 个研究点目标入组 80 人开始时间: 2020年11月26日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Diagnosis of a non-alcoholic fatty liver disease

排除标准

  • - Alcohol consumption = 20 g/d in female and = 30 g/d in male patients
  • - Decompensated cirrhosis of the liver
  • - Viral hepatitis
  • - Non-viral primary or secondary liver diseases other than NAFLD/NASH
  • - Malignancies (except for basalioma) within the last 5 years, in particular primary or secondary liver tumors
  • - Orthotopic liver transplantation
  • - Any comedication known to cause hepatic steatosis (i.e. steroids, Methotrexate, Amiodarone, Tamoxifen, Valproate, Flutamide, etc.)
  • - Clinically relevant heart insufficiency, cardiac arrhythmias, relevant cardiac valve diseases
  • - Pregnancy and lactation

研究者

相似试验